A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 2)
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The Stage 2 of this phase 2 study is an open-label, single-arm study to assess the efficacy
and safety of CBL-514 in participants with Edematous Fibrosclerotic Panniculopathy (EFP)
cellulite.